| Institution: | 1. Velindre Hospital, United Kingdom;2. Jewish General Hospital, Canada;3. OptumInsight Life Sciences, Sweden;4. Hôpital Saint Antoine, France;5. Boehringer Ingelheim Pharmaceuticals Inc., USA;6. St. Antonius Ziekenhuis, Netherlands;7. Boehringer Ingelheim Pharma GmbH, Germany;8. Olivia Newton-John Cancer and Wellness Centre, Austin Health, Australia;9. University Hospital Leuven, Belgium;10. St. Joseph-Hospital, Germany;11. Ege University, Turkey;1. Department of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands;2. Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands;3. Department of Radiation Oncology, Amsterdam Medical Centre, The Netherlands;4. Department of Research, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands;5. Institute of Radiooncology, Helmholtz Zentrum Dresden-Rossendorf, Germany;6. OncoRay, National Center for Radiation Research in Oncology, Dresden, Germany;7. Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany;1. Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women''s Cancer Center, Boston, Massachusetts, USA;2. Harvard Medical School, Boston, Massachusetts, USA;3. Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;4. Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA;1. Cardiovascular Medicine, Jiangsu Subei People''s Hospital, China;2. Cardiovascular Medicine, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China;1. Champalimaud Cancer Center, Lisbon, Portugal;2. Acibadem Maslak Hospital Breast Health, Istanbul, Turkey;3. Fred Hutchinson Cancer Research Center, Seattle, WA, USA;4. Hospital Sirio Libanes, Sao Paulo, Brazil;5. Women''s College Research Institute, Faculty of Medicine, Dalla Lana School of Public Health, University of Toronto, Canada;6. Multinational Association of Supportive Care in Cancer, Shelburne, VT, USA;7. Albert Einstein University, New York, NY, USA;8. Reach to Recovery International; Reach to Recovery South Africa, Cape Town, South Africa;9. European School of Oncology and Institute of Oncology of Southern Switzerland, Viganello, Switzerland;10. Dana-Farber Cancer Institute, New Bedford, MA, USA;11. Harvard Global Equity Initiative, Boston, MA, USA;12. Tómatelo a Pecho A.C., Mexico City, Mexico;13. Clinique de Genolier, Genolier, Switzerland;14. Ohio State University, Columbus, OH, USA;15. Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA |
